Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited (KIMS) is a mid-cap Healthcare company valued at ₹28,796 crore operating in Hospital on the NSE and BSE.

Recent price move

Krishna Institute of Medical Sciences Limited last traded at ₹685.05, modestly down 0.52% on the day.

Recent developments

On 2026-09-30, hospital stocks, including KIMS, fell up to 6% as the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospitals. The court's remarks on drug prices triggered pressure on the sector, affecting the company's stock price.

Financial performance

The company's revenue grew 28.7% annually, but net profit fell 41.7% year-on-year. In the latest quarter, revenue rose 35.3% compared to the same quarter a year earlier, but net profit dropped 56.0%, reflecting a widening gap between revenue growth and profit performance.

Valuation multiples

The stock trades at 113.6 times earnings, a premium to the Healthcare median of 32.0, 8.66 times book value.

Things to watch

The company's net profit margin fell 7.5 percentage points to 6.2%, and its debt to equity ratio remains high at 1.89. The company has not paid dividends despite reporting profits, and its stock is 17.8% below its 52-week high.

Where it stands

KIMS reported annual revenue growth of 28.7% but a sharp decline in net profit of 41.7%, with the latest quarter showing a 56.0% drop in net profit despite a 35.3% revenue increase. The stock is 17.8% below its 52-week high, and the company has not paid dividends despite repeated profits.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.